ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2017

Abstract Number: 770

Integrating Analysis of Skin RNA in Situ Hybridization Using Rnascope and Whole Skin Gene Expression in Systemic Sclerosis Skin to Localize Key Pathogenic Drivers of Skin Fibrosis

Corrado Campochiaro1, Emma C. Derrett-Smith1, Voon H. Ong2, Gail Pearse3, Katherine Nevin3, Shaun Flint3, Mary Morse3, Nicolas Wisniacki4 and Christopher Denton5, 1Centre for Rheumatology and Connective Tissue Diseases, UCL Division of Medicine, London, United Kingdom, 2Rheumatology, UCL Division of Medicine, London, United Kingdom, 3GlaxoSmithKline, Stevenage, United Kingdom, 4ImmunoImflammation, GlaxoSmithKline, Stevenage, United Kingdom, 5Department of Rheumatology, University College London, Royal Free Hospital, London, United Kingdom

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2017

Date of first publication: September 18, 2017

Keywords: Gene Expression, RNA, Scleredema and skin fibrosis

Session Information

Date: Sunday, November 5, 2017

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Pathogenesis, Animal Models and Genetics Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Skin gene expression profiling can distinguish SSc from normal skin and can detect different subsets of disease. Previous studies have reported a cross-sectional relationship between the expression of genes in whole skin and the modified Rodnan skin score (mRSS). We aim to compare gene expression in early versus late dcSSc and define cells responsible for the upregulation of candidate genes.

Methods: Total RNA was extracted from forearm skin biopsies of 3 early dcSSc anti-RNA polymerase III positive (ARA+) patients and 3 late dcSSc ARA+ patients. COMP, chemokine ligand 2 (CCL2), PDGF-A, collagen type I a 1 chain (COL1A1), interferon Induced Protein 44 (IFI44), IL-6, MMP3, SERPINE, TGF-b and thrombospondin 1 (THBS1) was measured using quantitative PCR analysis. mRSS was assessed in all patients and correlated with normalized gene expression. RNA in situ hybridization for a-actin-2 (ACTA2), CCL2, COL1A1, COL3A1, COMP, SERPINE and THBS1 mRNA was performed using RNAscope¨ 2.5 LS Reagent Kit in early dcSSc ARA+ patients (n=2) and healthy controls (HC) (n=3). Semi-quantitative scoring criteria were applied (score from 0 to 4).

Results: Whole skin relative normalized gene expression of COMP, CCL2, IL-6, SERPINE and THBS1 was significantly (p < 0.05) higher in early compared to late SSc skin (COMP mean 25049.15 ± 10862.16 vs 5256.47 ± 2380.53; CCL2 mean 1722.04 ± 598.93 vs 638.25 ± 279.96; IL-6 mean 43.98 ± 40.76 vs 11.91 ± 5.44; SERPINE mean 1770.32 ± 704.46 vs 184.48 ± 61.37; THBS1 mean 7190.75 ± 309.89 vs 1176.81 ± 235.35) [Figure 1]. There was a positive correlation between SERPINE and THBS1 and mRSS (SERPINE r2 = 0.493, p = 0.09; THBS1 r2 = 0.91, p = 0.02). Whole skin relative normalized gene expression of all the remaining genes, except for IFI44, was also higher in early compared to late patients although not significantly.  RNAscope analysis revealed positive SERPINE staining in subsets of fibroblast-like cells located in the mid-dermis in early dcSSc only (score 3 and 4 in early dcSSc vs score 0 in HCs). An increased number of THBS1+ and COMP+ fibroblast-like cells (α-smooth muscle actin +)  were found in the deep dermis of early dcSSc (score 4 in early dcSSc pts vs score 0, 2 and 3 in HCs).

Conclusion: SERPINE, THBS1, COMP, CCL2 and IL-6 are upregulated in early compared to late dcSSc patients. THBS1 and COMP are key genes associated with skin involvement and both are TGF-b regulated. RNAscope technology not only confirmed the upregulation of SERPINE, COMP and THBS1 in early dcSSc, but detected the expression of these genes in the dermis of patients in subsets of cells. These findings highlight how specific cells may be responsible for the pro-fibrotic and inflammatory changes typical of the early stages of the disease. Upregulation of fundamental pro-fibrotic and inflammatory genes could be crucial in the early stages of SSc and specific subsets of cells in the dermis could be the responsible for this. 


Disclosure: C. Campochiaro, None; E. C. Derrett-Smith, None; V. H. Ong, None; G. Pearse, GlaxoSmithKline, 3,GlaxoSmithKline, 1; K. Nevin, GlaxoSmithKline, 3,GlaxoSmithKline, 1; S. Flint, GlaxoSmithKline, 3,GlaxoSmithKline, 1; M. Morse, GlaxoSmithKline, 3,GlaxoSmithKline, 1; N. Wisniacki, GlaxoSmithKline, 1,GlaxoSmithKline, 3; C. Denton, Actelion, Pfizer, GlaxoSmithKline, Bayer, Sanofi-Aventis, Boehringer Ingelheim, Genentech-Roche, CSL Behring, Biogen, 5,Actelion, GlaxoSmithKline, Bayer, Genentech-Roche, CSL Behring, 2.

To cite this abstract in AMA style:

Campochiaro C, Derrett-Smith EC, Ong VH, Pearse G, Nevin K, Flint S, Morse M, Wisniacki N, Denton C. Integrating Analysis of Skin RNA in Situ Hybridization Using Rnascope and Whole Skin Gene Expression in Systemic Sclerosis Skin to Localize Key Pathogenic Drivers of Skin Fibrosis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/integrating-analysis-of-skin-rna-in-situ-hybridization-using-rnascope-and-whole-skin-gene-expression-in-systemic-sclerosis-skin-to-localize-key-pathogenic-drivers-of-skin-fibrosis/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/integrating-analysis-of-skin-rna-in-situ-hybridization-using-rnascope-and-whole-skin-gene-expression-in-systemic-sclerosis-skin-to-localize-key-pathogenic-drivers-of-skin-fibrosis/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology